This inventor holds 2 USPTO granted patents. Top assignees: Haemopep Pharma Gmbh, Pharis Biotec Gmbh. Active years: 2001-2003.
Location History:
- Hannover, DE (2001)
- Heidelberg, DE (2003)
Company Filing History:
Years Active: 2001-2003
Title: Manfred Raida: Innovator in Medical Diagnostics
Introduction
Manfred Raida is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of medical diagnostics, particularly through his innovative approaches to analyzing protein-level mutations. With a total of 2 patents, Raida's work has the potential to impact healthcare significantly.
Latest Patents
Raida's latest patents include groundbreaking inventions such as antibiotic peptides derived from bovine milk and a method for the direct diagnostic detection of genetically caused pathogenic point mutations. The latter invention focuses on a rapid method for qualitative and quantitative medical-diagnostic analysis at the protein level. This method involves enzymatic or chemical cleavage of isolated peptides, followed by chromatographical separation of the fragments and analysis through mass spectrometry techniques, including both direct LC/MS and indirect MALDI-MS, as well as capillary electrophoresis. By comparing protein samples from healthy individuals with those from patients, this method is designed to identify new mutations and quantify the expression of wild type to mutant proteins.
Career Highlights
Throughout his career, Raida has worked with notable companies such as Haemopep Pharma GmbH and Pharis Biotec GmbH. His expertise in medical diagnostics has positioned him as a valuable asset in the research and development of innovative healthcare solutions.
Collaborations
Raida has collaborated with esteemed colleagues, including Wolf-Georg Forssmann and Hans-Dieter Zucht. These partnerships have further enhanced his research and contributed to the advancement of medical diagnostics.
Conclusion
Manfred Raida's contributions to the field of medical diagnostics through his patents and collaborations highlight his role as an influential inventor. His innovative methods have the potential to revolutionize the way genetic mutations are detected and analyzed in the medical field.